Four Crucial Questions about the Humira Biosimilar Price War (rerun)
Drug Channels
OCTOBER 3, 2023
CVS Health launched Cordavis, a new subsidiary that will market a private label, low-list-price version of Sandoz’ Hyrimoz. Surprisingly, two PBMs—Express Scripts and OptumRx—will each offer at least one low-list-price biosimilar option on their main national formularies. d/b/a Drug Channels Institute.
Let's personalize your content